发明公开
- 专利标题： SMALL MOLECULE DRUG (ELP-004) TO PREVENT BONE LESIONS CAUSED BY MULTIPLE MYELOMA
-
申请号： US18438308申请日： 2024-02-09
-
公开(公告)号： US20240277631A1公开(公告)日： 2024-08-22
- 发明人: John B. Barnett , Werner Geldenhuys , Jonathan Soboloff , Harry Colbert Blair , Jamie McCall
- 申请人： West Virginia University Board of Governors on behalf of West Virginia University , Temple University-Of the Commonwealth System of Higher Education , University of Pittsburgh-Of the Commonwealth System of Higher Education
- 申请人地址： US WV Morgantown
- 专利权人： West Virginia University Board of Governors on behalf of West Virginia University,Temple University-Of the Commonwealth System of Higher Education,University of Pittsburgh-Of the Commonwealth System of Higher Education
- 当前专利权人： West Virginia University Board of Governors on behalf of West Virginia University,Temple University-Of the Commonwealth System of Higher Education,University of Pittsburgh-Of the Commonwealth System of Higher Education
- 当前专利权人地址： US WV Morgantown
- 主分类号： A61K31/136
- IPC分类号： A61K31/136 ; A61K31/69 ; A61P35/00
摘要：
A method of inhibiting the development of osteoclasts in patients having multiple myeloma comprising administering to a patient having multiple myeloma a therapeutically effective amount of N-Methyl-dichloropropionaniline (i.e. also known as ELP-004) for inhibiting the development of osteoclasts. The method includes wherein said N-Methyl-dichloropropionaniline is administered to said patient in a pharmaceutically acceptable vehicle.
信息查询
